Premium
High cancer drug prices 4 years later—Progress and prospects
Author(s) -
Kantarjian Hagop,
Patel Yogin
Publication year - 2017
Publication title -
cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.052
H-Index - 304
eISSN - 1097-0142
pISSN - 0008-543X
DOI - 10.1002/cncr.30545
Subject(s) - medicine , legislation , remedial education , cancer drugs , cancer , drug , drug prices , law , public economics , pharmacology , economics , political science
High cancer drug prices continue to be a significant problem in the United States despite the existence of remedial solutions that can be readily implemented with appropriate legislation. See also pages 1313‐23.